COVID-19 Vaccines for Adults and Children
A Study of COVID-19 Vaccine(s) in Children and Adults
Recruiting
Phase 3
Interventional Study
COVID-19 Vaccines
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 5 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 700 (estimated)
- Sponsor
- BioNTech SE · Industry
Who this trial is looking for
This trial is looking for children and adults who are at risk for serious COVID-19. Participants will receive a COVID-19 vaccine injection and report any side effects over about 6 months.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 5 years of age or older.
- I have at least 1 medical condition that increases my risk of severe COVID-19.
You may not be able to join if
- I have had a severe allergic reaction to a vaccine.
- I have a history of myocarditis or pericarditis.
- I received a COVID-19 vaccine or tested positive for COVID-19 in the last 90 days.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The purpose of this study is to learn about the safety and effects of updated COVID-19 vaccines (called BNT162b2) in participants 5 Through 64 Years of Age with risk factors for Severe COVID-19, and Participants 65 Years of Age and Older.
This study is seeking participants who:
* are medically stable
* have not had a recent COVID-19 infection or a recent COVID-19 vaccination
* have not received …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Key Inclusion criteria:
* Participants 5 years of age or older.
* Participants 5 through 64 years of age should have at least 1 underlying medical condition that increases their risk of severe COVID-19.
Key Exclusion Criteria:
* History of severe adverse reaction associated with a vaccine and/or …
Contacts